CERS logo

Cerus (CERS)

Profile

Full Name

Cerus Corporation

Ticker Symbol

CERS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

January 31, 1997

Indexes

Not included

Website

http://www.cerus.com

Employees

614

Key Details

Price

$1.35(-0.74%)

Market cap

$250.82M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$180.27M(+15.29% YoY)

Annual EPS

-$0.11(+47.62% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.35
CERS price is $1.35

30-Day Relative Volume

0.90
CERS 30-day relative volume is 0.90

Price Performance

Price Most recent change

-0.74%
CERS price was down -0.74% on Apr 25, 2025

Price YTD change

-12.34%
CERS price is down -12.34% since January 1st

Price 1-year change

-20.59%
CERS price is down -20.59% year-on-year

Price 3-year change

-71.82%
CERS price is down -71.82% over the past 3 years

Price Range

Price All-time high

$81.88
CERS price is currently -98.35% below its historical high of $81.88

Price 3-year low

$1.12
CERS price is currently +20.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$250.82M
CERS market capitalization is $250.82 million

Market cap 3-year change

-70.4%
CERS market capitalization is down -70.4% over the past 3 years

Market cap All-time high

$1.43B
CERS market capitalization is currently -82.47% below its historical high of $1.43 billion

Market cap sector rank

59.32%
CERS market capitalization is higher than 59.32% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.49%
CERS shares outstanding is up +0.49% year-on-year

Shares Outstanding 3-Year Change

+5.03%
CERS shares outstanding is up +5.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.57
CERS beta is 1.57

200-day SMA

$1.79
CERS price is currently -24.56% below its 200-day simple moving average

50-day SMA

$1.48
CERS price is currently -8.67% below its 50-day simple moving average

RSI

47.33
CERS 14-day relative strength index is 47.33

Volume

0.90
CERS 30-day relative volume is 0.90

ATR

$0.09
CERS average true range is $0.09

10-day Historical Volatility

69.19%
CERS 10-day historical volatility is 69.19%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$180.27M
CERS annual revenue is $180.27 million

Revenue Analysts estimate

$214.27M
CERS annual revenue is currently -15.87% lower than the consensus analysts' forecast

Revenue 1-year change

+15.29%
CERS annual revenue is up +15.29% year-on-year

Revenue Sector rank

62%
CERS annual revenue is higher than 62% of companies in Healthcare sector

EPS

EPS

-$0.11
CERS annual earnings per share is -$0.11

EPS Analysts estimate

-$0.11
CERS annual earnings per share is currently equal to the consensus analysts' forecast

EPS 1-year change

+47.62%
CERS annual earnings per share is up +47.62% year-on-year

EPS Sector rank

79.63%
CERS annual earnings per share is higher than 79.63% of companies in Healthcare sector

Profit

Gross profit

$99.52M
CERS annual gross profit is $99.52 million

Gross margin

55.21%
CERS annual gross profit margin is 55.21%

Operating profit

-$14.22M
CERS annual operating income is -$14.22 million

Operating margin

-7.89%
CERS annual operating profit margin is -7.89%

Net income

-$20.92M
CERS annual net profit is -$20.92 million

Net margin

-11.60%
CERS annual net profit margin is -11.60%

Expenses

Total expenses

$194.50M
CERS annual total expenses is $194.50 million

Operating expenses

$113.75M
CERS annual total operating expenses is $113.75 million

Cost of goods sold

$80.75M
CERS annual cost of goods sold is $80.75 million

Selling, general & administrative expenses

$75.89M
CERS annual SGA is $75.89 million

Depreciation and amortization

$1.85M
CERS annual depreciation & amortization is $1.85 million

Interest expense

$8.88M
CERS annual interest expense is $8.88 million

Income tax

$205.00K
CERS annual income tax is $205.00 thousand

EBIT & EBITDA

EBIT

-$14.22M
CERS annual earnings before interest & taxes is -$14.22 million

EBITDA

-$14.22M
CERS annual EBITDA is -$14.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$200.92M
CERS annual total assets is $200.92 million

Non current assets

$48.90M
CERS annual long term assets is $48.90 million

Current assets

$152.02M
CERS annual total current assets is $152.02 million

Cash and cash equivalents

$20.27M
CERS annual cash & cash equivalents is $20.27 million

Accounts receivable

$29.78M
CERS annual accounts receivable is $29.78 million

Inventory

$38.15M
CERS annual inventory is $38.15 million

Liabilities

Total liabilities

$144.02M
CERS annual total liabilities is $144.02 million

Long term liabilities

$80.41M
CERS annual total long term liabilities is $80.41 million

Current liabilities

$63.61M
CERS annual total current liabilities is $63.61 million

Accounts payable

$40.64M
CERS annual accounts payable is $40.64 million

Debt

Total debt

$98.10M
CERS annual total debt is $98.10 million

Total debt 1-year change

+2.19%
CERS annual total debt is up +2.19% year-on-year

Long term debt

$76.53M
CERS annual long term debt is $76.53 million

Short term debt

$21.57M
CERS annual short term debt is $21.57 million

Equity & Capital

Shareholders equity

$56.15M
CERS annual stockholders equity is $56.15 million

Book value

$56.15M
CERS annual book value is $56.15 million

Retained earnings

-$1.07B
CERS annual retained earnings is -$1.07 billion

Working capital

$88.41M
CERS annual working capital is $88.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$11.36M
CERS annual cash flow from operations is $11.36 million

Cash from operations 1-year change

+126.31%
CERS annual cash flow from operations is up +126.31% year-on-year

Cash from investing

-$8.13M
CERS annual cash flow from investing activities is -$8.13 million

Cash from investing 1-year change

-194.27%
CERS annual cash flow from investing activities is down -194.27% year-on-year

Cash from financing

$4.96M
CERS annual cash flow from financing activities is $4.96 million

Cash from financing 1-year change

-53.49%
CERS annual cash flow from financing activities is down -53.49% year-on-year

CAPEX

CAPEX

$2.84M
CERS annual capital expenditures is $2.84 million

CAPEX 1-year change

-38.29%
CERS annual capital expenditures is down -38.29% year-on-year

Free Cash Flow

Free cash flow

$8.52M
CERS annual free cash flow is $8.52 million

Free cash flow 1-year change

+117.84%
CERS annual free cash flow is up +117.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

55.21%
CERS annual gross profit margin is 55.21%

Operating margin

-7.89%
CERS annual operating profit margin is -7.89%

Net margin

-11.60%
CERS annual net profit margin is -11.60%

ROA & ROE

ROA

-10.49%
CERS annual return on assets is -10.49%

ROE

-37.92%
CERS annual return on equity is -37.92%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CERS price to earnings ratio value is unknown

PE ratio Sector rank

-
CERS price to earnings ratio is unknown

PB Ratio

PB ratio

4.47
CERS price to book ratio is 4.47

PB ratio Sector rank

80.48%
CERS price to book ratio is higher than 80.48% of companies in Healthcare sector

PS Ratio

PS ratio

1.39
CERS price to sales ratio is 1.39

PS ratio Sector rank

32.86%
CERS price to sales ratio is higher than 32.86% of companies in Healthcare sector

Enterprise value

Enterprise value

$328.65M
CERS enterprise value is $328.65 million

Enterprise value Sector rank

63.05%
CERS enterprise value is higher than 63.05% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-28.81
CERS EV/EBITDA is -28.81

EV/EBITDA Sector rank

4.84%
CERS EV/EBITDA is higher than 4.84% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.39
CERS annual current ratio is 2.39

Quick ratio

1.79
CERS annual quick ratio is 1.79

Leverage

Debt to equity

1.50
CERS annual debt to equity ratio is 1.50

Interest coverage ratio

-1.60
CERS annual interest coverage ratio is -1.60

Risk & Stability

Piotroski F-Score

4
CERS piotroski f-score is 4

Altman Z-Score

-5.19
CERS altman z-score is -5.19

Analyst ratings

Recent major analysts updates

Feb 21, 25 Cantor Fitzgerald
Overweight
Oct 17, 24 Stifel
Buy
May 3, 24 Cantor Fitzgerald
Overweight
Apr 12, 24 Craig-Hallum
Buy
Mar 7, 24 Stephens & Co.
Equal-Weight
Mar 6, 24 Cantor Fitzgerald
Overweight
Jan 20, 23 BTIG
Neutral
May 27, 20 Stifel
Buy
Apr 16, 20 Stephens & Co.
Overweight
Feb 26, 20 BTIG Research
Buy

Institutional Ownership

Similar stocks

VNDA logo
Vanda Pharmaceuticals (VNDA)
Atlantic International (ATLN)
CRVS logo
Corvus Pharmaceuticals (CRVS)
AVIR logo
Atea Pharmaceuticals (AVIR)
TERN logo
Terns Pharmaceuticals (TERN)
NRC logo
National Research (NRC)
SLDB logo
Solid Biosciences (SLDB)
NVCT logo
Nuvectis Pharma (NVCT)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
  • What is the ticker symbol for Cerus?
  • Does Cerus pay dividends?
  • What sector is Cerus in?
  • What industry is Cerus in?
  • What country is Cerus based in?
  • When did Cerus go public?
  • Is Cerus in the S&P 500?
  • Is Cerus in the NASDAQ 100?
  • Is Cerus in the Dow Jones?
  • When was Cerus's last earnings report?
  • When does Cerus report earnings?
  • Should I buy Cerus stock now?

What is the ticker symbol for Cerus?

The ticker symbol for Cerus is NASDAQ:CERS

Does Cerus pay dividends?

No, Cerus does not pay dividends

What sector is Cerus in?

Cerus is in the Healthcare sector

What industry is Cerus in?

Cerus is in the Medical Devices industry

What country is Cerus based in?

Cerus is headquartered in United States

When did Cerus go public?

Cerus's initial public offering (IPO) was on January 31, 1997

Is Cerus in the S&P 500?

No, Cerus is not included in the S&P 500 index

Is Cerus in the NASDAQ 100?

No, Cerus is not included in the NASDAQ 100 index

Is Cerus in the Dow Jones?

No, Cerus is not included in the Dow Jones index

When was Cerus's last earnings report?

Cerus's most recent earnings report was on Feb 20, 2025

When does Cerus report earnings?

The next expected earnings date for Cerus is May 1, 2025

Should I buy Cerus stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page